Automatic Immunoassay Analyzer Market Outlook:
Automatic Immunoassay Analyzer Market size was over USD 6.9 billion in 2024 and is set to reach USD 15.8 billion by the end of 2037, growing at around 7.9% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of automatic immunoassay analyzer is evaluated at USD 7.4 billion.
The global market is steadily expanding, since there is an expanded patient pool requiring diagnostic testing, especially for chronic and infectious diseases. As stated in the World Health Organization report, the burden of infectious diseases led to 17.5% deaths in 2023, and the chronic conditions, such as diabetes and cardiovascular diseases, are at a surge, augmenting the demand for high-throughput immunoassay systems. Besides, the U.S. CDC notes that above 44% of adults in the country are diagnosed with at least one chronic condition necessitating frequent diagnosis. Therefore, this has created an increased necessity, positively influencing the market across all nations.
Furthermore, the global burden led to increased procurement of automated analyzers in healthcare facilities, with over 58% of clinical labs in the U.S. currently relying on high-volume immunoassay platforms. On the other hand, the trade data from the U.S. International Trade Commission notes that China and Mexico are leading exporters of immunoassay analyzer subcomponents; simultaneously, the U.S. and EU are reported to be leading in finished device imports, thereby making a standard contribution towards the market upliftment.
